Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Huntington's disease
Huntington's disease
Wave culls leading Huntington's meds as shares go under after rival Roche hit by similar fate
Fierce Biotech
Tue, 03/30/21 - 11:36 am
Wave Life Sciences
Huntington's disease
Roche cuts bait on late-stage study of Huntington's med tominersen, an Ionis import with prior safety flags
Endpoints
Mon, 03/22/21 - 09:56 pm
Roche
Huntington's disease
tominersen
Wave gets another shot at Huntington’s
EP Vantage
Mon, 03/22/21 - 10:39 am
Wave Life Sciences
WVE-120102
Huntington's disease
Years after a major trial setback, Novartis switches gears with SMA drug. This time they're trying it for Huntington's
Endpoints
Wed, 10/21/20 - 11:43 pm
Novartis
SMA
branaplam
Huntington's disease
Voyager Takes a Hit After FDA Places Hold on Gene Therapy for Huntington's Disease
BioSpace
Tue, 10/13/20 - 11:01 am
Voyager Therapeutics
gene therapy
FDA
Huntington's disease
VY-HTT01
UniQure gets out the gate first in race for Huntington's gene therapy
BioPharma Dive
Sat, 06/20/20 - 09:41 pm
uniQure
clinical trials
Huntington's disease
AMT-130
Roche Trial of Ionis Huntington’s Disease Drug Halted After Side Effects
Xconomy
Thu, 03/5/20 - 11:12 pm
Ionis Pharmaceuticals
Huntington's disease
clinical trials
tominersen
Wave tanks again as Huntington's clinical trial data underwhelm
Fierce Biotech
Thu, 01/2/20 - 10:54 am
Wave Life Sciences
Huntington's disease
clinical trials
WVE-120102
Triplet Therapeutics Unveils $59M to Try Hairpin Fix for Huntington’s
Xconomy
Tue, 12/17/19 - 09:22 pm
Triplet Therapeutics
Huntington's disease
A clinical trial for Huntington’s opens the door to hope for some patients. Only so many can get in
Stat
Wed, 12/4/19 - 10:25 am
Huntington's disease
clinical trials
patients
Teva forecasts 'tenfold' growth for new launch Austedo. Why don't analysts agree?
Fierce Pharma
Wed, 11/20/19 - 10:26 pm
Teva Pharmaceutical
Austedo
Huntington's disease
tardive dyskinesia
Upcoming events – Wave takes on Huntington's and Argenx goes subcutaneous
EP Vantage
Fri, 11/15/19 - 11:14 am
Wave Life Sciences
WVE-120101
Huntington's disease
Argenx
efgartigimod
autoimmune disease
UniQure presses go on Huntington’s gene therapy trial
Pharmaforum
Mon, 10/28/19 - 10:41 am
uniQure
Huntington's disease
gene therapy
AMT-130
clinical trials
UniQure snags patents on Huntington's gene therapy as it preps for the clinic
Biopharma Dive
Wed, 05/22/19 - 09:06 pm
uniQure
gene therapy
Huntington's disease
clinical trials
AMT-130
Experimental Drug For Huntington's Disease Jams Malfunctioning Gene
NPR
Fri, 05/10/19 - 10:27 am
Huntington's disease
RG6042
clinical trials
Roche
Genentech
EIP bags cash to trial ex-Vertex drug in dementia, Huntington's
Fierce Biotech
Mon, 04/15/19 - 10:00 am
EIP Pharma
Alzheimer's disease
dementia
Huntington's disease
Roche gets some regulatory love for its breakthrough quest on a PhIII Huntington’s drug
Endpoints
Fri, 08/3/18 - 11:31 pm
Roche
EMA
Europe
RG6042
IONIS-HTTRx
Huntington's disease
Teva’s one-time blockbuster-to-be — and now recurring embarrassment — laquinimod fails yet again, this time for Huntington’s
Endpoints
Tue, 07/31/18 - 12:25 pm
Teva Pharmaceutical
Active Biotech
Huntington's disease
clinical trials
laquinimod
Roche, Ionis herald a big win in early-stage Huntington’s disease trial, demonstrate disease modifying potential
Endpoints
Thu, 03/1/18 - 11:48 pm
Roche
Ionis Pharmaceuticals
clinical trials
Huntington's disease
IONIS-HTT Rx
Roche snaps up Huntington's drug on positive data
BioPharma Dive
Thu, 12/14/17 - 09:14 am
Roche
Huntington's disease
Ionis Pharmaceuticals
IONIS-HTTRx
Pages
« first
‹ previous
1
2
3
4
5
next ›
last »